Diligent Pharma, a Princeton, NJ-based private vendor qualification and risk management organization, raised $8.27M in Series A funding. The round was led by FCA Venture Partners with participation from PJC, and GenHenn Capital. The company intends to use the funds to scale its data and content strategy. Led by CEO and Founder Patty Leuchten, Diligent [...]The post Diligent Pharma Closes $8.27M Series A Financing appeared first on FinSMEs.
Diligent is a New Jersey-based SaaS platform that provides solutions such as trial monitoring and vendor quality management for sectors including biotech and pharmaceuticals.